Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models.

PubWeight™: 2.09‹?› | Rank: Top 2%

🔗 View Article (PMC 1301545)

Published in Biophys J on August 01, 2001

Authors

D C Chow1, L A Wenning, W M Miller, E T Papoutsakis

Author Affiliations

1: Department of Chemical Engineering, Northwestern University, Evanston, Illinois 60208-3120, USA.

Articles citing this

The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell (2010) 5.07

Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A (2007) 4.81

TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med (2008) 4.76

Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci U S A (2012) 3.21

Direct measurement of local oxygen concentration in the bone marrow of live animals. Nature (2014) 2.21

Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood (2006) 1.79

Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol (2010) 1.62

Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cells. J Biol Chem (2008) 1.52

AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia. Blood (2015) 1.52

Hypoxia-driven pathways in bone development, regeneration and disease. Nat Rev Rheumatol (2012) 1.36

Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a Wnt4-dependent pathway. Mol Ther (2010) 1.31

Hypoxia-inducible factors in stem cells and cancer. J Cell Mol Med (2009) 1.27

EF1alpha and RPL13a represent normalization genes suitable for RT-qPCR analysis of bone marrow derived mesenchymal stem cells. BMC Mol Biol (2010) 1.21

p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced death. Blood (2007) 1.18

Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic condition. J Cell Biochem (2011) 1.12

Benefits of hypoxic culture on bone marrow multipotent stromal cells. Am J Blood Res (2012) 1.11

Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy. ScientificWorldJournal (2013) 1.10

The bone marrow microenvironment as niche retreats for hematopoietic and leukemic stem cells. Adv Hematol (2013) 1.09

Bone marrow osteoblastic niche: a new model to study physiological regulation of megakaryopoiesis. PLoS One (2009) 1.08

Impairment of osteoblast differentiation due to proliferation-independent telomere dysfunction in mouse models of accelerated aging. Aging Cell (2012) 1.07

Atmospheric oxygen inhibits growth and differentiation of marrow-derived mouse mesenchymal stem cells via a p53-dependent mechanism: implications for long-term culture expansion. Stem Cells (2012) 1.00

Hypoxia-mediated efficient expansion of human tendon-derived stem cells in vitro. Tissue Eng Part A (2011) 1.00

Up-regulation of glycolytic metabolism is required for HIF1α-driven bone formation. Proc Natl Acad Sci U S A (2014) 0.99

Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production. Tissue Eng Part A (2013) 0.98

The evolving role of the aryl hydrocarbon receptor (AHR) in the normophysiology of hematopoiesis. Stem Cell Rev (2012) 0.98

Many mechanisms mediating mobilization: an alliterative review. Curr Opin Hematol (2011) 0.98

High targeted migration of human mesenchymal stem cells grown in hypoxia is associated with enhanced activation of RhoA. Stem Cell Res Ther (2013) 0.97

Reactive oxygen species regulate hematopoietic stem cell self-renewal, migration and development, as well as their bone marrow microenvironment. Antioxid Redox Signal (2014) 0.96

Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis. Stem Cell Res Ther (2015) 0.95

Surviving change: the metabolic journey of hematopoietic stem cells. Trends Cell Biol (2014) 0.93

To breathe or not to breathe: the haematopoietic stem/progenitor cells dilemma. Br J Pharmacol (2013) 0.91

The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications. ScientificWorldJournal (2011) 0.91

A central role for hypoxic signaling in cartilage, bone, and hematopoiesis. Curr Osteoporos Rep (2011) 0.90

Enhanced growth of myelodysplastic colonies in hypoxic conditions. Exp Hematol (2007) 0.89

Effects of severe hypoxia on bone marrow mesenchymal stem cells differentiation potential. Stem Cells Int (2013) 0.88

Initial testing of the hypoxia-activated prodrug PR-104 by the pediatric preclinical testing program. Pediatr Blood Cancer (2010) 0.87

ROS-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation. Cell Death Dis (2013) 0.85

Resilient and resourceful: genome maintenance strategies in hematopoietic stem cells. Exp Hematol (2013) 0.85

HIF1α is a regulator of hematopoietic progenitor and stem cell development in hypoxic sites of the mouse embryo. Stem Cell Res (2013) 0.84

MiR-17 partly promotes hematopoietic cell expansion through augmenting HIF-1α in osteoblasts. PLoS One (2013) 0.83

The Key Role of the Blood Supply to Bone. Bone Res (2013) 0.83

Oxidants, metabolism, and stem cell biology. Free Radic Biol Med (2011) 0.82

Isolation of mouse mesenchymal stem cells with normal ploidy from bone marrows by reducing oxidative stress in combination with extracellular matrix. BMC Cell Biol (2011) 0.82

Bone marrow niche-inspired, multiphase expansion of megakaryocytic progenitors with high polyploidization potential. Cytotherapy (2010) 0.82

Microenvironment at tissue injury, a key focus for efficient stem cell therapy: A discussion of mesenchymal stem cells. World J Stem Cells (2009) 0.81

Targeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidence. Ther Adv Hematol (2016) 0.80

Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures. Prostate (2016) 0.80

Bone marrow microenvironment modulation of acute lymphoblastic leukemia phenotype. Exp Hematol (2015) 0.80

The soluble form of LR11 protein is a regulator of hypoxia-induced, urokinase-type plasminogen activator receptor (uPAR)-mediated adhesion of immature hematological cells. J Biol Chem (2013) 0.80

Biology of the bone marrow microenvironment and myelodysplastic syndromes. Mol Genet Metab (2015) 0.80

Modeling Chemotherapy Resistant Leukemia In Vitro. J Vis Exp (2016) 0.79

Effect of low oxygen tension on the biological characteristics of human bone marrow mesenchymal stem cells. Cell Stress Chaperones (2016) 0.79

The haematopoietic stem cell niche: new insights into the mechanisms regulating haematopoietic stem cell behaviour. Stem Cells Int (2011) 0.79

Histological assessment of tissue from large human bone defects repaired with β-tricalcium phosphate. Eur J Orthop Surg Traumatol (2013) 0.79

Very low oxygen concentration (0.1%) reveals two FDCP-Mix cell subpopulations that differ by their cell cycling, differentiation and p27KIP1 expression. Cell Death Differ (2010) 0.78

Hypoxia regulates the hematopoietic stem cell niche. Pflugers Arch (2015) 0.78

Human parvovirus B19: a mechanistic overview of infection and DNA replication. Future Virol (2015) 0.78

Mesenchymal stem cell response to growth factor treatment and low oxygen tension in 3-dimensional construct environment. Muscles Ligaments Tendons J (2014) 0.77

Carbon monoxide induced erythroid differentiation of K562 cells mimics the central macrophage milieu in erythroblastic islands. PLoS One (2012) 0.77

Numerical modeling of oxygen distributions in cortical and cancellous bone: oxygen availability governs osteonal and trabecular dimensions. Am J Physiol Cell Physiol (2010) 0.77

Low Oxygen Modulates Multiple Signaling Pathways, Increasing Self-Renewal, While Decreasing Differentiation, Senescence, and Apoptosis in Stromal MIAMI Cells. Stem Cells Dev (2016) 0.77

Hypoxia inducible factor-stabilizing bioactive glasses for directing mesenchymal stem cell behavior. Tissue Eng Part A (2014) 0.76

BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy. Oncotarget (2016) 0.76

Hypoxia and Hypoxia-Inducible Factors in Leukemias. Front Oncol (2016) 0.76

Bone Marrow Microenvironment Niche Regulates miR-221/222 in Acute Lymphoblastic Leukemia. Mol Cancer Res (2016) 0.75

Progressive Muscle Cell Delivery as a Solution for Volumetric Muscle Defect Repair. Sci Rep (2016) 0.75

Effects of CreERT2, 4-OH Tamoxifen, and Gender on CFU-F Assays. PLoS One (2016) 0.75

Stem cell autotomy and niche interaction in different systems. World J Stem Cells (2015) 0.75

Hierarchy of breast cancer cells: key to reverse dormancy for therapeutic intervention. Stem Cells Transl Med (2014) 0.75

Hypoxic Niche-Mediated Regeneration of Hematopoiesis in the Engraftment Window Is Dominantly Affected by Oxygen Tension in the Milieu. Stem Cells Dev (2015) 0.75

Integration of hypoxic HIF-α signaling in blood cancers. Oncogene (2017) 0.75

Hypoxic Three-Dimensional Scaffold-Free Aggregate Cultivation of Mesenchymal Stem Cells in a Stirred Tank Reactor. Bioengineering (Basel) (2017) 0.75

Bone Cell Bioenergetics and Skeletal Energy Homeostasis. Physiol Rev (2017) 0.75

Articles cited by this

Modeling pO(2) distributions in the bone marrow hematopoietic compartment. I. Krogh's model. Biophys J (2001) 1.79

A theoretical analysis of the effect of the particulate nature of blood on oxygen release in capillaries. Microvasc Res (1986) 1.49

On facilitated oxygen diffusion in muscle tissues. Biophys J (1980) 1.16

Reduced oxygen tension increases hematopoiesis in long-term culture of human stem and progenitor cells from cord blood and bone marrow. Exp Hematol (1992) 1.12

Characterization of hematopoietic cell expansion, oxygen uptake, and glycolysis in a controlled, stirred-tank bioreactor system. Biotechnol Prog (1998) 1.10

A model study of intracellular oxygen gradients in a myoglobin-containing skeletal muscle fiber. Biophys J (1986) 1.06

The influence of oxygen tension on the long-term growth in vitro of haematopoietic progenitor cells from human cord blood. Br J Haematol (1986) 1.05

The effect of reduced oxygen tension on colony formation of erythropoietic cells in vitro. Br J Haematol (1982) 1.02

Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages. Exp Hematol (1998) 1.00

Physiologically significant effects of pH and oxygen tension on granulopoiesis. Exp Hematol (2000) 0.95

Geometric considerations in modeling transport processes in tissue. Adv Exp Med Biol (1973) 0.93

The effect of cell size and capillary spacing on myocardial oxygen supply. Adv Exp Med Biol (1984) 0.92

The relationship of stromal cells to hemopoietic cells in marrow. Kroc Found Ser (1984) 0.90

Microcirculation and transport of oxygen to neurons of the brain. Microvasc Res (1979) 0.89

A role for the macrophage in normal hemopoiesis. II. Effect of varying physiological oxygen tensions on the release of hemopoietic growth factors from bone-marrow-derived macrophages in vitro. Exp Hematol (1986) 0.87

Diffusion pathways in oxygen supply of cardiac muscle. Adv Exp Med Biol (1987) 0.87

The macrophage as a production site for hematopoietic regulator molecules: sensing and responding to normal and pathophysiological signals. Anticancer Res (1988) 0.85

Modelling erythrocytes as point-like O2 sources in a Kroghian cylinder model. Adv Exp Med Biol (1994) 0.84

Oxygen diffusive shunts under conditions of heterogeneous oxygen delivery. J Theor Biol (1982) 0.84

A new mathematical approach for solving carrier-facilitated steady-state diffusion problems. J Math Biol (1979) 0.83

Measurement of the oxygen diffusion coefficient in the subcutis of man. Acta Physiol Scand (1961) 0.83

Articles by these authors

In vivo methylation in Escherichia coli by the Bacillus subtilis phage phi 3T I methyltransferase to protect plasmids from restriction upon transformation of Clostridium acetobutylicum ATCC 824. Appl Environ Microbiol (1993) 2.70

Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjects. Clin Pharmacol Ther (2007) 2.53

Expression of cloned homologous fermentative genes in Clostridium acetobutylicum ATCC 824. Biotechnology (N Y) (1992) 2.39

Thiolase from Clostridium acetobutylicum ATCC 824 and Its Role in the Synthesis of Acids and Solvents. Appl Environ Microbiol (1988) 2.31

The genes for butanol and acetone formation in Clostridium acetobutylicum ATCC 824 reside on a large plasmid whose loss leads to degeneration of the strain. J Bacteriol (1997) 2.15

Molecular characterization of an aldehyde/alcohol dehydrogenase gene from Clostridium acetobutylicum ATCC 824. J Bacteriol (1994) 1.87

Determination of the HIV integrase inhibitor, MK-0518 (raltegravir), in human plasma using 96-well liquid-liquid extraction and HPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 1.81

Modeling pO(2) distributions in the bone marrow hematopoietic compartment. I. Krogh's model. Biophys J (2001) 1.79

Genetic manipulation of acid formation pathways by gene inactivation in Clostridium acetobutylicum ATCC 824. Microbiology (1996) 1.78

Molecular characterization of two Clostridium acetobutylicum ATCC 824 butanol dehydrogenase isozyme genes. J Bacteriol (1992) 1.77

Coenzyme A transferase from Clostridium acetobutylicum ATCC 824 and its role in the uptake of acids. Appl Environ Microbiol (1989) 1.73

Development and characterization of a gene expression reporter system for Clostridium acetobutylicum ATCC 824. Appl Environ Microbiol (1999) 1.58

Cloning and expression of Clostridium acetobutylicum ATCC 824 acetoacetyl-coenzyme A:acetate/butyrate:coenzyme A-transferase in Escherichia coli. Appl Environ Microbiol (1990) 1.52

Antisense RNA strategies for metabolic engineering of Clostridium acetobutylicum. Appl Environ Microbiol (1999) 1.50

Cloning and expression of Clostridium acetobutylicum phosphotransbutyrylase and butyrate kinase genes in Escherichia coli. J Bacteriol (1988) 1.46

Phosphotransbutyrylase from Clostridium acetobutylicum ATCC 824 and its role in acidogenesis. Appl Environ Microbiol (1989) 1.45

Characterization of recombinant strains of the Clostridium acetobutylicum butyrate kinase inactivation mutant: need for new phenomenological models for solventogenesis and butanol inhibition? Biotechnol Bioeng (2000) 1.44

Sequence and arrangement of two genes of the butyrate-synthesis pathway of Clostridium acetobutylicum ATCC 824. Gene (1993) 1.43

Purification and characterization of the NADH-dependent butanol dehydrogenase from Clostridium acetobutylicum (ATCC 824). Arch Biochem Biophys (1989) 1.39

Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1. Clin Pharmacol Ther (2007) 1.39

Regulation of the sol locus genes for butanol and acetone formation in Clostridium acetobutylicum ATCC 824 by a putative transcriptional repressor. J Bacteriol (1999) 1.25

Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation. Am J Transplant (2014) 1.24

The effect of pH on nitrogen supply, cell lysis, and solvent production in fermentations of Clostridium acetobutylicum. Biotechnol Bioeng (1985) 1.16

n-3 and n-6 fatty acid processing and growth effects in neoplastic and non-cancerous human mammary epithelial cell lines. Br J Cancer (1994) 1.15

Solventogenesis in Clostridium acetobutylicum fermentations related to carboxylic acid and proton concentrations. Biotechnol Bioeng (1988) 1.15

Metabolic engineering of Clostridium acetobutylicum ATCC 824 for increased solvent production by enhancement of acetone formation enzyme activities using a synthetic acetone operon. Biotechnol Bioeng (1993) 1.14

Stoichiometric modeling of Clostridium acetobutylicum fermentations with non-linear constraints. J Biotechnol (1999) 1.13

Demethylation studies. VI. The inhibition of hepatic microsomal oxygenation by 2,4-dichloro(6-phenylphenoxy)ethylamine and related compounds. J Med Chem (1969) 1.12

Reduced oxygen tension increases hematopoiesis in long-term culture of human stem and progenitor cells from cord blood and bone marrow. Exp Hematol (1992) 1.12

Epidemiological studies of calf respiratory disease in a large commercial veal unit. Res Vet Sci (1980) 1.10

Characterization of hematopoietic cell expansion, oxygen uptake, and glycolysis in a controlled, stirred-tank bioreactor system. Biotechnol Prog (1998) 1.10

Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocytes. Br J Haematol (2000) 1.09

Metabolic flux analysis elucidates the importance of the acid-formation pathways in regulating solvent production by Clostridium acetobutylicum. Metab Eng (1999) 1.08

Expression of plasmid-encoded aad in Clostridium acetobutylicum M5 restores vigorous butanol production. J Bacteriol (1994) 1.08

Influence of cellular trafficking on protein synthesis inhibition of immunotoxins directed against the transferrin receptor. Cancer Res (1995) 1.08

Fermentation characterization and flux analysis of recombinant strains of Clostridium acetobutylicum with an inactivated solR gene. J Ind Microbiol Biotechnol (2001) 1.06

Expression of Clostridium acetobutylicum ATCC 824 genes in Escherichia coli for acetone production and acetate detoxification. Appl Environ Microbiol (1998) 1.05

Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval. J Clin Pharmacol (2008) 1.02

Culture pH affects expression rates and glycosylation of recombinant mouse placental lactogen proteins by Chinese hamster ovary (CHO) cells. Biotechnology (N Y) (1993) 1.01

Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages. Exp Hematol (1998) 1.00

Effects of elevated pCO(2) and/or osmolality on the growth and recombinant tPA production of CHO cells. Biotechnol Bioeng (1996) 0.99

Cloning of an NADH-dependent butanol dehydrogenase gene from Clostridium acetobutylicum. Ann N Y Acad Sci (1991) 0.97

Higher pH promotes megakaryocytic maturation and apoptosis. Stem Cells (2002) 0.97

Low oxygen tension enhances the stimulation and proliferation of human T lymphocytes in the presence of IL-2. Cytotherapy (2000) 0.97

Vector construction, transformation, and gene amplification in Clostridium acetobutylicum ATCC 824. Ann N Y Acad Sci (1992) 0.97

Culture materials affect ex vivo expansion of hematopoietic progenitor cells. J Biomed Mater Res (1997) 0.96

Hematopoietic cell culture therapies (Part I): Cell culture considerations. Trends Biotechnol (1996) 0.95

Physiologically significant effects of pH and oxygen tension on granulopoiesis. Exp Hematol (2000) 0.95

Declining sexually transmitted infections among female sex workers: the results of an HIV and sexually transmitted infection prevention strategy in Honduras, 2006-08. Int J STD AIDS (2012) 0.94

Genetic and metabolic engineering of Clostridium acetobutylicum ATCC 824. Ann N Y Acad Sci (1994) 0.94

Determination of antibody content in live versus dead hybridoma cells: analysis of antibody production in osmotically stressed cultures. Biotechnol Bioeng (1992) 0.94

A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: effect of nutrient concentration, dilution rate, and pH. Reprinted from Biotechnology and Bioengineering, Vol. 32, Pp 947-965 (1988). Biotechnol Bioeng (2000) 0.94

Production of tPA in recombinant CHO cells under oxygen-limited conditions. Biotechnol Bioeng (1993) 0.93

Determination of plasmid copy number and stability in Clostridium acetobutylicum ATCC 824. FEMS Microbiol Lett (1993) 0.92

Stirred culture of peripheral and cord blood hematopoietic cells offers advantages over traditional static systems for clinically relevant applications. Biotechnol Bioeng (1998) 0.92

Low oxygen tension and autologous plasma enhance T-cell proliferation and CD49d expression density in serum-free media. Cytotherapy (2001) 0.92

Damage mechanisms of suspended animal cells in agitated bioreactors with and without bubble entrainment. Biotechnol Bioeng (1990) 0.91

Ammonia affects the glycosylation patterns of recombinant mouse placental lactogen-I by chinese hamster ovary cells in a pH-dependent manner. Biotechnol Bioeng (1994) 0.91

pH is a potent modulator of erythroid differentiation. Br J Haematol (1998) 0.91

The lactate issue revisited: novel feeding protocols to examine inhibition of cell proliferation and glucose metabolism in hematopoietic cell cultures. Biotechnol Prog (2000) 0.90

Oxygen tension modulates the expression of cytokine receptors, transcription factors, and lineage-specific markers in cultured human megakaryocytes. Exp Hematol (2001) 0.90

The AutoPap system for primary screening in cervical cytology. Comparing the results of a prospective, intended-use study with routine manual practice. Acta Cytol (1998) 0.90

Culture of human T cells in stirred bioreactors for cellular immunotherapy applications: shear, proliferation, and the IL-2 receptor. Biotechnol Bioeng (2000) 0.89

Effects of CO2 and osmolality on hybridoma cells: growth, metabolism and monoclonal antibody production. Cytotechnology (1998) 0.89

Effects of propionate and acetate additions on solvent production in batch cultures of Clostridium acetobutylicum. Appl Environ Microbiol (1990) 0.88

Studies of recombinant Clostridium acetobutylicum with increased dosages of butyrate formation genes. Ann N Y Acad Sci (1994) 0.88

Effects of abrupt and gradual osmotic stress on antibody production and content in hybridoma cells that differ in production kinetics. Biotechnol Prog (1994) 0.88

Considerations for osmolality measurement under elevated pCO(2): comparison of vapor pressure and freezing point osmometry. Biotechnol Bioeng (2000) 0.88

Pharmacokinetics, pharmacodynamics, and safety of a prostaglandin D2 receptor antagonist. Clin Pharmacol Ther (2007) 0.87

Evaluation of cytokines for expansion of the megakaryocyte and granulocyte lineages. Stem Cells (1997) 0.87

Cloning, structure, and expression of acid and solvent pathway genes of Clostridium acetobutylicum. Biotechnology (1993) 0.86

Phosphate feeding improves high-cell-concentration NS0 myeloma culture performance for monoclonal antibody production. Biotechnol Bioeng (2000) 0.86

Effects of synergistic cytokine combinations, low oxygen, and irradiated stroma on the expansion of human cord blood progenitors. Blood (1992) 0.86

Physical mechanisms of cell damage in microcarrier cell culture bioreactors. Biotechnol Bioeng (1988) 0.86

A study of the potential economic impact of foot and mouth disease in the United States. Proc Annu Meet U S Anim Health Assoc (1977) 0.86

Diversity in the ability of cultured cells to elongate and desaturate essential (n-6 and n-3) fatty acids. Ann N Y Acad Sci (1994) 0.86

Diverse effects of essential (n-6 and n-3) fatty acids on cultured cells. Cytotechnology (1994) 0.85

Protection mechanisms of freely suspended animal cells (CRL 8018) from fluid-mechanical injury. Viscometric and bioreactor studies using serum, pluronic F68 and polyethylene glycol. Biotechnol Bioeng (1991) 0.85

Ammonia inhibits neural cell adhesion molecule polysialylation in Chinese hamster ovary and small cell lung cancer cells. J Cell Physiol (1998) 0.84

Methods for cloning key primary metabolic enzymes and ancillary proteins associated with the acetone-butanol fermentation of Clostridium acetobutylicum. Ann N Y Acad Sci (1990) 0.84

Sparging and agitation-induced injury of cultured animals cells: Do cell-to-bubble interactions in the bulk liquid injure cells? Biotechnol Bioeng (1996) 0.84

Hematopoietic cell culture therapies (Part II): Clinical aspects and applications. Trends Biotechnol (1996) 0.84